Thursday, April 18, 2019 12:27:36 AM
Marcus Whitney Robins
Date of birth: December 8 2053
Date of death: April 5 2019
Marcus "Marc" Whitney Robins, 65, passed away quietly as a result of a circulatory ailment Friday, April 5, 2019, at OHSU Hospital in Portland, OR. Born to Dr. and Mrs. George Robins of Portland, he graduated from Willamette University, B.S., 1976, and Willamette's Atkinson School of Business Administration, M.B.A., 1979.
Marcus had a long career in Portland as a Chartered Financial Analyst. He was the principal creator of the Red Chip Review with an emphasis on small cap investments, for which he specialized. Later, he formed The Robins Group and Catalyst Research Management Group. His business relationships spanned the continent, from the West Coast to Wall Street.
In recent years, he wrote a book about his time spent in the small cap world - Confessions of a Ten-Bagger Junkie - explaining his investment philosophy and telling some of the stories of the people and companies with whom he had dealt. He also enjoyed bee-keeping, served on the Underwood Community Center Board, and was the CEO of Skunk Brothers Distillery in Stevenson, WA.
Marc was an active member of the Episcopal Church, including attendance in Portland, Hood River and Joseph, OR.
He is survived by his wife, Barbara (née Napp) Robins, his children Kent Robins (Allie) of Yelm, WA, Clara (née Robins) Brandt (Taylor) of Portland, and Bryant Robins of Bellingham, WA, as well as two grandchildren. Marc and Barbara were lately residents of Underwood, WA., near Hood River. He is also survived by his brothers, Thomas Robins of Bellingham, WA and Philip Robins of Portland. He had the joy of meeting his two grandchildren before his passing.
A time to gather and say "Farewell to the Ten-Bagger Junkie" is planned at Trinity Lutheran Church, 5520 NE Killingsworth, Portland, OR 97218, May 18th, from 2-5 PM. Please RSVP: https://docs.google.com/forms/d/e/1FAIpQLScVA3AlyrNV13N6kChyg4zhGvFl3JdD4p1MMengoPDMmNm-HQ/viewform?usp=sf_link. In lieu of flowers, please consider donating to the Underwood Parks and Recreation District.
Recent AEMD News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 12:01:08 PM
- Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India • PR Newswire (US) • 09/19/2024 12:01:00 PM
- Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial • PR Newswire (US) • 09/16/2024 12:01:00 PM
- Aethlon Medical to Present at the Life Sciences Investor Forum September 19th • GlobeNewswire Inc. • 09/13/2024 12:35:00 PM
- Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys • PR Newswire (US) • 08/27/2024 12:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/15/2024 08:34:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/15/2024 08:32:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/15/2024 08:30:33 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/15/2024 08:15:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 09:10:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:15:21 PM
- Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update • PR Newswire (US) • 08/14/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:01:08 PM
- Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial • PR Newswire (US) • 08/12/2024 12:01:00 PM
- Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024 • PR Newswire (US) • 08/06/2024 01:12:00 PM
- Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update • PR Newswire (US) • 06/27/2024 08:15:00 PM
- Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 • PR Newswire (US) • 06/21/2024 12:01:00 PM
- Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial • PR Newswire (US) • 06/18/2024 12:01:00 PM
- Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies • PR Newswire (US) • 06/03/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 05:24:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:28 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/16/2024 08:05:23 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM